Cardiff Oncology: Q2 Earnings Snapshot

SAN DIEGO (AP) — SAN DIEGO (AP) — Cardiff Oncology, Inc. (CRDF) on Tuesday reported a loss of $9.2 million in its second quarter.

On a per-share basis, the San Diego-based company said it had a loss of 14 cents.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.

The molecular diagnostic company posted revenue of $104,000 in the period, which met Street forecasts.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRDF at https://www.zacks.com/ap/CRDF